NEW YORK--(BUSINESS WIRE)--IRX Therapeutics, a privately-held company dedicated to the development and commercialization of novel drugs for the treatment of cancer and viral diseases, today announced that Declan P. Doogan, M.D., FRCP (Glas), FFPM, DSc has joined the Company as an advisor on global product development and strategic partnering.
